Skip to main content

CITIGROUP INC

Position in NMRA — Neumora Therapeutics, Inc.

CIK 831001 NEW YORK, NY

Position in NMRA

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$89,254
-$5,892 QoQ
Shares Held
52,503
+7.6% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 111 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NMRA Over Time

Shares Held

Position Value (USD)

Derivatives in NMRA

reported options exposure · as of Dec 31, 2024
CallValue
$0
CallShares
0
PutValue
$1,057,880
PutShares
99,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. NMRA ranks #265 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NMRA

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $89,254 52,503
2026-03-31 $95,146 48,793
2025-12-31 $78,459 43,832
2025-09-30 $10,850 5,962
2025-06-30 $14,019 19,126
2025-03-31 $65,847 65,847
2024-12-31 $1,139,044 107,457
2024-12-31 $1,057,880 99,800
2024-09-30 $895,347 67,778
2024-06-30 $203,559 20,708
2024-03-31 $941,297 68,458
2023-12-31 $97,969 5,746
2023-09-30 $203,409 14,416